C, S., CW, H., E, L., DJ, M., G, L., A, F., & R, H. (2023). A translational pharmacokinetic/pharmacodynamic approach supports optimal vonoprazan dosing for erosive oesophagitis and Helicobacter pylori infection. Alimentary pharmacology & therapeutics, 58(1), 16. https://doi.org/10.1111/apt.17510
Chicago Style (17th ed.) CitationC, Scarpignato, Howden CW, Leifke E, Mulford DJ, Lahu G, Facius A, and Hunt R. "A Translational Pharmacokinetic/pharmacodynamic Approach Supports Optimal Vonoprazan Dosing for Erosive Oesophagitis and Helicobacter Pylori Infection." Alimentary Pharmacology & Therapeutics 58, no. 1 (2023): 16. https://doi.org/10.1111/apt.17510.
MLA (9th ed.) CitationC, Scarpignato, et al. "A Translational Pharmacokinetic/pharmacodynamic Approach Supports Optimal Vonoprazan Dosing for Erosive Oesophagitis and Helicobacter Pylori Infection." Alimentary Pharmacology & Therapeutics, vol. 58, no. 1, 2023, p. 16, https://doi.org/10.1111/apt.17510.